Atlas Trials

A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation

Clinical trial NCT05545202 · UNKNOWN

Trial details

NCT number
NCT05545202
Sponsor
Pharmacosmos A/S
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Malignant LymphomaMultiple Myeloma
Start date
2024-04-30
Primary completion
2025-02-15
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.